Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.
The Cure Starts Now has funded $25,395,277 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 167 grants at over 100 hospitals in 29 countries.
Cincinnati Children's Hospital - $176,186
$176,186.00
November 2014
International DIPG Registry
University of California, San Francisco - $100,000
$100,000.00
September 2014
Single-cell profiling and targeting of developmentally regulated signaling programs in DIPG.
VU University Medical Center - $30,529
$30,529.00
September 2014
European DIPG Registry
Institute of Cancer Research - $95,325
$95,325.00
September 2014
The evolutionary dynamics of DIPG
The Hospital of Sick Children - $99,400
$99,400.00
September 2014
Development of subgroup-specific models of paediatric DIPG
Duke University Medical Center - $85,394
$85,394.00
November 2013
Development of peptide vaccine for diffuse intrinsic pontine glioma
Yale University - $100,000
$100,000.00
November 2013
Pre-Clinical Development of Novel DIPG Radiosensitizers
Monash Institute of Medical Research - $99,620
$99,620.00
November 2013
Targeted Therapy and Stem Cell Therapy for DIPG
Cincinnati Children's Hospital - $205,000
$205,000.00
November 2013
Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry
Ann and Robert H. Lurie Children's Hospital of Chicago - $100,000
$100,000.00
November 2013
Ex-vivo expanded natural killer (NK) cells to target DIPG tumor cells in pre-clinical studies
The Hospital of Sick Children - $100,000
$100,000.00
November 2013
Investigating Mechanisms of Therapeutic Resistance in DIPG.
Dana-Farber Cancer Institute - $50,000
$50,000.00
November 2013
Phase II Trial of Molecularly Determined Treatment of Children and Young Adults with Newly Diagnosed Diffuse Intrinsic Pontine Gliomas.
Texas Children's Cancer Center - $100,000
$100,000.00
November 2013
Targeting DIPGs in vivo in Intra-brain Stem Xenograft Mouse Models through Combined Radiation and Oncolytic Viral Therapy.
Children's National Medical Center - $99,979
$99,979.00
November 2013
Comparative Proteomic and RNA Sequencing of DIPGs
Sydney Children's Hospital - $100,000
$100,000.00
January 2013
Research of treatments for Diffuse Intrinsic Pontine Glioma (DIPG)